Feb 17, 2025
MIND diet ranked no. 1 for brain health
Published February 3, 2025 | Originally published on Newswise: Health Food A diet created by researchers at Rush is ranked among the top diets for 2025 by U.S. News & World Report. Best Diets…
Resources
Feb 14, 2025
FDA approves amended label for Izervay for geographic atrophy
February 13, 2025 By Emily Kaiser Maharjan, Assistant Managing Editor The approval follows a refiling after the FDA issued a Complete Response Letter regarding language on the amended label. The FDA…
Feb 11, 2025
Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg
February 10, 2025, By Martin David Harp Results were published from the phase 3 QUASAR trial and the extension study of the phase 3 PULSAR trial. Regeneron Pharmaceuticals has announced results…
Feb 11, 2025
February is Low Vision Awareness Month
Did you know that? Statistics show that low vision affects 2.2 billion people globally, and 12 million in the US, impacting their daily lives. Low Vision can result due to…
Feb 10, 2025
Federal Policy Announcements and Discussions about Funding Research
Dear Macular Degeneration Association Friends, The recent federal policy announcements and discussions about funding research have raised questions from our donors about the potential impact on biomedical research.…
Feb 10, 2025
February is Macular Degeneration Awareness Month
Here is important information about macular degeneration, which is known as the number one cause of irreversible blindness and visual impairment in the older population. Age-related macular degeneration (AMD) is…
Feb 4, 2025
Notal Vision publishes positive results from pivotal study of AI algorithm in home-based OCT system
Author(s): Martin David Harp Key Takeaways The AI algorithm demonstrated strong repeatability and agreement with expert graders in segmenting hypo-reflective spaces in nAMD patients. The AI’s repeatability in…
Feb 4, 2025
February is Age-Related Macular Degeneration Month
February is Age-Related Macular Degeneration (AMD) Awareness Month Did you know that there are three forms of age-related macular degeneration? Dry AMD is a…
Feb 4, 2025
Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy
Using Artificial Intelligence to Investigate the Real-world effect of Anti-complement Medications on Retinal Photoreceptor Survival in Patients with Geographic Atrophy- Research project funded by the Macular Degeneration Association Principal Investigator: …
Feb 3, 2025
Intracranial pressure levels may be a critical factor in glaucoma
Key takeaways: Glaucoma may be a result of two pressures: IOP and intracranial pressure. When one pressure is high and the other is low, it results in ganglion cell proptosis,…
Jan 31, 2025
Opening our eyes to the impact of preservatives
January 30, 2025 By Elyse Rayborn, OD, MBA, FAAO Chris Lievens, OD, MS, FAAO, FNAP Optometry Times JournalJanuary/February digital edition 2025 Preservatives may disrupt the ocular surface, contributing to poor adherence.…
Jan 31, 2025
Are Blueberries Good for Diabetes?
Blueberries are packed with vitamins, antioxidants, and minerals that promote overall health. For people living with diabetes, blueberries may also help with glucose processing, weight loss, and insulin sensitivity. Blueberry…
Jan 29, 2025
Stop drinking coffee wrong: Here’s the healthiest time for caffeine
By Elizabeth Pratt | Fact-checked by Davi Sherman | Published January 27, 2025 Industry Insights “It’s not just whether you drink coffee or how much you drink, but [also] the time of day when you drink coffee, that’s…
Jan 24, 2025
Dispelling eye health myths seen on social media
By Dagny Zhu, MD The contents of this article are informational only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment recommendations. This editorial…
Jan 21, 2025
Living with Wet AMD – Tips for Maintaining Independence
by: Jarred Long, OD – Low Vision Optometrist A diagnosis of wet age-related macular degeneration (AMD) can feel overwhelming, but it doesn’t have to mean giving up the activities…
Jan 20, 2025
Soliddd Introduces its SolidddVision Smartglasses Technology at CES 2025
Patented virtual reality smartglasses are the first true vision correction for people living with vision loss due to macular degeneration Published on: 07 Jan 2025, 8:43 am LAS VEGAS and NEW YORK,…
Jan 9, 2025
One Small Step for Geographic Atrophy: Monitor Your Cholesterol and Blood Pressure Levels
Take Aways Blood Pressure Cholesterol Keeping track of these numbers could help slow the progression of age-related macular degeneration and delay vision loss if you already have geographic atrophy. Geographic…
Jan 1, 2025
Happy New Year 2025
Happy New Year May this year bring, joy, peace, and hope.
Dec 24, 2024
Happy Holidays
Happy Holidays from everyone at the Macular Degeneration Association. As the year ends, we thank you for your never-ending support. New research & treatments are transforming the landscape for…
Dec 23, 2024
First of its kind study lists health benefits of drinking more water each day
Published December 18, 2024 | Originally published on ScienceAlert Latest We all know that staying hydrated is good for human health – but a new study goes into more specific detail about all the various benefits…
Dec 20, 2024
A look at geographic atrophy in 2024: The highs, lows of treatment trials
By: Kate Young-Fact checked by: Heather Biele In 2024, Healio covered several stories about trials investigating geographic atrophy biomarkers and treatment options. While one trial found that intravitreal pegcetacoplan showed…
Dec 17, 2024
The Macular Degeneration Association Welcomes New Medical Board Member
The Macular Degeneration Association (MDA) is proud to welcome Jessica Cameron, OD, FAAO as one of our distinguished Medical Board members. Dr. Cameron is a low vision specialist. She owns…
Dec 17, 2024
Press Release – EYLEA HD Phase 3 Trial results (QUASAR trial)
Eylea HD injection of 8 gm in the Phase 3 trial (QUASAR trial) is meeting the primary endpoints showing improved vision with extended dosing intervals in patients with macular…
Dec 16, 2024
Galimedix Therapeutics initiates phase 1 trial of oral GAL-101
Author(s): David Hutton Key Takeaways GAL-101 targets misfolded amyloid beta monomers, preventing toxic oligomer and protofibril formation, with potential applications in Alzheimer’s, dry AMD, and glaucoma. The Phase 1 trial…
Dec 12, 2024
Exclusive 20% Off on Your Eye Care Essentials!
As part of our ongoing commitment to your eye health, we wanted to alert you about our partnership with DryEye Rescue, a trusted provider of specialized eye care products.…
Dec 10, 2024
‘Not all chocolate is created equal’: New data imply the dark variety lowers diabetes risk
By: Andrew (Drew) Rhoades Fact checked by: Gina Brockenbrough, MA Key takeaways: Eating 5 ounces or more of chocolate a week lowered type 2 diabetes risk. Results showed no link…
Dec 10, 2024
ARCHER trial shows benefit of ANX007 on vision loss in geographic atrophy
By: Michela Cimberle Fact checked by Christine Klimanskis, ELS BARCELONA, Spain — In the phase 2 ARCHER trial, ANX007, a novel C1q inhibitor with neuroprotective properties, showed consistent protection against loss of…
Dec 9, 2024
Is Nutrition The Culprit? With Dr. Poteet
A new video discusses nutrition and its affects on our bodies and our eyes. Did you know your nutrition can impact your risk of disease? Dr. Julie Poteet is a…
Dec 3, 2024
Sun Pharma announces positive Phase 4 data results in dry eye disease
Author(s): David Hutton Key Takeaways Cyclosporine ophthalmic solution 0.09% significantly improves dry eye disease symptoms in patients inadequately controlled on Restasis. The Phase 4 study showed sustained improvements in corneal…
Nov 27, 2024
Happy Thanksgiving
Happy Thanksgiving from our families to yours. We are grateful for your support and friendship. We will be closed on Thursday & Friday in observance of the Holiday.